Owner Wilex AG

Inventors Oosterwijk, Egbert; Warbaar, Sven; Ullrich, Stefan

Agent Davies Collison Cave

Pub. Number AU-B-2002238537

PCT Pub. Number WO2002/062972

Priority 60/266,853 07.02.01 US; 60/327,008 05.10.01 US

Filing date 7 February 2002

Wipo publication date 19 August 2002

Acceptance publication date 20 July 2006

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells